Product Description
SARS-CoV-2 Spike RBD Antibody [2838] | 10-058 | ProSci
Host: N/A
Reactivity: Virus
Homology: N/A
Immunogen: Sequenced from human survivors of COVID-19 (SARS-CoV-2) . The spike RBD is expressed on the surface of SARS-CoV-2.
Research Area: Infectious Disease, COVID-19
Tested Application: E
Application: ELISA (Quality Tested by ProSci)
Specificiy: Anti-SARS-CoV-2 Spike RBD, clone 2838, specifically targets an epitope on the SARS-CoV-2 spike protein receptor-binding domain (RBD) . This antibody does not cross-react with the N-terminal domain (NTD) of the spike protein or the RBD of SARS-CoV.
Positive Control 1: N/A
Positive Control 2: N/A
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: N/A
Validation: N/A
Isoform: N/A
Purification: >95% by SDS Page
Clonality: Recombinant Monoclonal
Clone: 2838
Isotype: Human IgG1
Conjugate: Unconjugated
Physical State: Liquid
Buffer: This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium, calcium or preservatives added.
Concentration: >1.0 mg/ml
Storage Condition: Functional grade preclinical antibodies may be stored sterile as received at 2-8˚ C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80˚ C. Avoid Repeated Freeze Thaw Cycles.
Alternate Name: SARS-CoV-2 Spike RBD Antibody, Receptor Binding Domain Antibody
User Note: N/A
BACKGROUND: N/A